Sharda Solvent
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -60.1% over past five years.
- Company has a low return on equity of 4.07% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 5,026 days.
Technical Indicators
Oscillators
Neutral
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,192 | 2,461 | 2,478 | 1,883 | 2,134 | 2,485 | 2,030 | 1,394 | 1,694 | 2,276 | 1,988 | 1,602 | 2,308 |
| Expenses | 1,597 | 1,791 | 1,871 | 1,416 | 1,626 | 1,945 | 1,662 | 1,041 | 1,325 | 1,730 | 1,590 | 1,215 | 1,840 |
| Operating Profit | 595 | 670 | 607 | 467 | 508 | 540 | 368 | 353 | 370 | 545 | 398 | 387 | 468 |
| OPM % | 27% | 27% | 25% | 25% | 24% | 22% | 18% | 25% | 22% | 24% | 20% | 24% | 20% |
| Other Income | 17 | 31 | 21 | 26 | 25 | 343 | 20 | 82 | 154 | 136 | 92 | 50 | 91 |
| Interest | 117 | 121 | 137 | 145 | 155 | 128 | 103 | 112 | 113 | 121 | 117 | 126 | 153 |
| Depreciation | 61 | 59 | 60 | 62 | 61 | 61 | 63 | 63 | 61 | 57 | 52 | 51 | 49 |
| PBT | 434 | 521 | 432 | 287 | 316 | 694 | 222 | 260 | 350 | 504 | 321 | 260 | 356 |
| Tax % | 25% | 25% | 28% | 24% | 23% | 20% | 30% | 26% | 25% | 20% | 24% | 27% | 27% |
| Net Profit | 324 | 390 | 310 | 217 | 243 | 553 | 156 | 194 | 263 | 403 | 244 | 190 | 259 |
| EPS (₹) | 33.47 | 40.3 | 32.05 | 22.46 | 25.1 | 57.29 | 16.08 | 19.98 | 27.05 | 41.75 | 25.23 | 19.91 | 26.79 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|
| Sales | 412 | 424 | 1,185 | 1,252 | 544 | 567 | 11.66 | 12.68 |
| Expenses | 413 | 414 | 1,126 | 1,197 | 545 | 567 | 14.64 | 15.27 |
| Operating Profit | -0.86 | 10.23 | 59.79 | 55.27 | -0.44 | 0.09 | -2.98 | -2.59 |
| OPM % | -0.21% | 2.41% | 5.04% | 4.41% | -0.08% | 0.02% | -25.56% | -20.43% |
| Other Income | 10 | 0.79 | 9.83 | 25.24 | 1.18 | 0.65 | 0.07 | 0.1 |
| Interest | 4.72 | 5.87 | 42.61 | 61.69 | 0 | 0 | 0 | 0 |
| Depreciation | 1.93 | 1.95 | 7.52 | 9.69 | 0.59 | 0.59 | 0.76 | 0.73 |
| PBT | 2.49 | 3.2 | 19.49 | 9.13 | 0.15 | 0.15 | -3.67 | -3.22 |
| Tax % | 12.85% | 35.62% | 47.2% | 47.97% | 6.67% | 120% | -638.42% | 0% |
| Net Profit | 2.17 | 2.06 | 10.29 | 4.75 | 0.14 | -0.02 | 19.76 | -3.22 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.05 | 5.05 | 5.05 | 5.05 | 5.55 | 5.55 | 5.55 | 5.55 |
| Reserves | 17.26 | 19.31 | 110 | 115 | 120 | 120 | 140 | 137 |
| Borrowings | 64.56 | 88.42 | 410 | 444 | 216 | 187 | 255 | 251 |
| Other Liabilities | 22.83 | 21.41 | 189 | 277 | 179 | 124 | 94.83 | 90.49 |
| Total Liabilities | 110 | 134 | 714 | 841 | 522 | 437 | 495 | 484 |
| Fixed Assets | 24.66 | 23.4 | 140 | 167 | 3.41 | 2.83 | 1.9 | 1.17 |
| CWIP | 0 | 0 | 28.16 | 0.3 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 7 |
| Other Assets | 85.04 | 111 | 546 | 674 | 518 | 434 | 493 | 476 |
| Total Assets | 110 | 134 | 714 | 841 | 522 | 437 | 495 | 484 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|
| Operating | — | — | 36.91 | 44.97 | 12.46 | 0.36 | -70.05 | 10.44 |
| Investing | — | — | -50.38 | -8.13 | 4.98 | 0.65 | 0.07 | -6.9 |
| Financing | — | — | 6.48 | -26.45 | 11.85 | -29.7 | 68.21 | -3.6 |
| Net Cash Flow | — | — | -6.99 | 10.39 | 29.29 | -28.69 | -1.77 | -0.05 |
| Free Cash Flow | — | — | -13.47 | 36.82 | 12.51 | 0.36 | -70.05 | 10.44 |
| CFO/OP | — | — | 63 | 83 | -2,834 | 400 | 2,351 | -403 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2010 | Mar 2011 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28.76 | 34.84 | 115 | 125 | 169 | 110 | 6,823 | 5,026 |
| Inventory Days | 40.51 | 51.8 | 36.66 | 58.73 | 144 | 157 | 8,698 | 8,001 |
| Days Payable | 15.88 | 14.35 | 56.75 | 79.06 | 37.54 | 4.9 | 237 | 602 |
| Cash Conversion Cycle | 53.39 | 72.28 | 94.59 | 104 | 275 | 263 | 15,285 | 12,425 |
| Working Capital Days | 58.05 | 77.39 | 108 | 112 | 269 | 261 | 14,812 | 12,715 |
| ROCE % | — | 9.09% | — | 12.94% | — | 0.05% | -1.03% | -0.81% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sharda Solvent insights
42 extracted metrics + investor summaries across FY06–FY26.
Documents
Frequently Asked Questions about Sharda Solvent
Where is Sharda Solvent Ltd (530679) listed?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530679.md for Sharda Solvent Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.